ECSP982603A - NEW HETERO CYCLIC COMPOUNDS - Google Patents

NEW HETERO CYCLIC COMPOUNDS

Info

Publication number
ECSP982603A
ECSP982603A ECSP982603A ECSP982603A EC SP982603 A ECSP982603 A EC SP982603A EC SP982603 A ECSP982603 A EC SP982603A EC SP982603 A ECSP982603 A EC SP982603A
Authority
EC
Ecuador
Prior art keywords
group
aromatic group
alkyl
cyclic compounds
hetero cyclic
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ferrer Jordi Gracia
Garcia Andres Fernandez
Noverola Armando Vega
Crespo Maria Isabel Crespo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982603 priority Critical patent/ECSP982603A/en
Publication of ECSP982603A publication Critical patent/ECSP982603A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos heterociclicos de fórmula (I) (gráfico), en donde R1 representa un átomo de hidrógeno o un grupo -(CH2)m-y y donde m es un número de 0 a 4 y representa un grupo alquilo, haloalquilo, alcoxi, alcoxicarbobino, C3-C7 cicloalquilo, norbornilo o fenilalquenilo, o un grupo aromático cuyo grupo aromático y opcionalmente esta sustituído por uno o mas átomos de halógeno R2 representa un grupo aromático, cuyo grupo aromático opcionalmente está sustituido por uno o más átomos de halógeno o grupos alquilo, alcoxi, C3-C6 cicloalcoxi, metilendioxi, nitro, dialquiilamino o trifluorometilo; y R3 representa un átomo de hidrógeno o halógeno o un grupo alquilo, y sales farmacéuticamente aceptables de los mismos, procedimientos para la preparación del mismo y su uso en tratamiento médico.Heterocyclic compounds of formula (I) (graph), where R1 represents a hydrogen atom or a group - (CH2) m and where m is a number from 0 to 4 and represents an alkyl, haloalkyl, alkoxy, alkoxycarbobin, C3 group -C7 cycloalkyl, norbornyl or phenylalkenyl, or an aromatic group whose aromatic group and optionally is substituted by one or more halogen atoms R2 represents an aromatic group, whose aromatic group is optionally substituted by one or more halogen atoms or alkyl, alkoxy groups , C3-C6 cycloalkoxy, methylenedioxy, nitro, dialkylamino or trifluoromethyl; and R3 represents a hydrogen or halogen atom or an alkyl group, and pharmaceutically acceptable salts thereof, processes for the preparation thereof and their use in medical treatment.

ECSP982603 1998-07-28 1998-07-28 NEW HETERO CYCLIC COMPOUNDS ECSP982603A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982603 ECSP982603A (en) 1998-07-28 1998-07-28 NEW HETERO CYCLIC COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982603 ECSP982603A (en) 1998-07-28 1998-07-28 NEW HETERO CYCLIC COMPOUNDS

Publications (1)

Publication Number Publication Date
ECSP982603A true ECSP982603A (en) 1999-02-11

Family

ID=42043523

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982603 ECSP982603A (en) 1998-07-28 1998-07-28 NEW HETERO CYCLIC COMPOUNDS

Country Status (1)

Country Link
EC (1) ECSP982603A (en)

Similar Documents

Publication Publication Date Title
CO4970780A1 (en) NEW PIRIDAZINE HETERO-CYCLE COMPOUNDS
NO20053460L (en) New compounds with selective inhibitory effect at GSK3
HUP0002461A2 (en) Tricyclic benzothiepin a benzoxepin derivatives and pharmaceutical compositions thereof
AR035153A1 (en) CARBOXAMID DERIVATIVES AND DIHYDROBENZODIOXINE KETONES
BR9307580A (en) Process compounds for the preparation of the same pharmaceutical compositions use of a compound and process for the treatment of a mammal that includes humans
EA200400507A1 (en) HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF URINARY TRACT DISEASES
DOP2002000399A (en) NEW DERIVATIVES OF SULFONIC ACID
DK0779284T3 (en) Novel 2-naphtanamide derivatives and their therapeutic uses as agonists of D3 receptors
DK26289D0 (en) USE OF 1,4-DISUBSTITUTED PIPERIDINYL FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR TREATING INSOMNIA
AR006261A1 (en) BRADIQUININE HETERO-CYCLIC ANTAGONISTS, SUBSTITUTED WITH FLUOROALKYL FLUOROALCOXI, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT AND SAID MEDICINAL PRODUCT
AR035451A1 (en) DERIVATIVES OF BETA-CARBOLINA, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DEPRESSION, ANXIETY AND BIPOLAR DISORDERS, A PHARMACEUTICAL COMPOSITION AND A COMBINATION.
ATE199543T1 (en) BIBPHENYLAMIDE DERIVATIVES AS 5-HT1D ANTAGONISTS
CO5540322A2 (en) NEW HETEROCICLIC DERIVATIVES THAT INCLUDE A RING OF TETRAHYDROISOQUINOLINE AND PHARMACEUTICAL USE OF THE SAME
AR021826A1 (en) COMPOUNDS OF 2- FENILPIRAN-4-ONA, PROCESSES TO PREPARE THEM, USE OF AN INTERMEDIATE COMPOUND IN THESE, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF SUCH COMPOUNDS AND SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DK0461958T3 (en) 2- (aminoalkyl) -5- (arylalkyl) -1,3-dioxane derivatives, process for their preparation and use in therapy
PT925295E (en) N-BENZENESULFONYL-1-PROLINE DERIVATIVES AS BRADIQUININ B2 AGONISTS
ECSP982603A (en) NEW HETERO CYCLIC COMPOUNDS
DK0888356T3 (en) Condensed 2,3-benzodiazepine derivatives and their use as AMPA receptor inhibitors
NO954091L (en) 1,5-Benzodinazine derivatives with CCK and / or gastrin antagonistic activity
AR045600A1 (en) TIENOIMIDAZOLES REPLACED, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC ASSISTANT AND MEDICINAL PRODUCT THAT INCLUDES THEM
BR9812928A (en) New 3-oxo- (2h) -1,2,4-triazine derivatives, process for preparing chemical compounds, and pharmaceutical composition
DK0784973T3 (en) Quinoxaline derivatives for the treatment of tinnitus
ES2051850T3 (en) PROCEDURE FOR PREPARING LEUCOTRENE ANTAGONISTS.
ATE356805T1 (en) OXOPHENYLCYCLOHEXYLPROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPEUTICS
DE60116655D1 (en) CARBATE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE